Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 5;15(8):e0237127.
doi: 10.1371/journal.pone.0237127. eCollection 2020.

SARS-CoV-2 detection in setting of viral swabs scarcity: Are MRSA swabs and viral swabs equivalent?

Daniel G Federman  1   2 , Shaili Gupta  1   2 , Gary Stack  1   2 , Sheldon M Campbell  1   2 , David R Peaper  1   2 , Louise M Dembry  1   2 , Ann Fisher  1   2 , Asim F Tarabar  1   2 , Michael Kozal  1   2 , Christopher B Ruser  1   2
Affiliations

SARS-CoV-2 detection in setting of viral swabs scarcity: Are MRSA swabs and viral swabs equivalent?

Daniel G Federman et al. PLoS One. .

Abstract

Background: The global pandemic of Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV2) has resulted in unprecedented challenges for healthcare systems. One barrier to widespread testing has been a paucity of traditional respiratory viral swab collection kits relative to the demand. Whether other sample collection kits, such as widely available MRSA nasal swabs can be used to detect SARS-CoV-2 is unknown.

Methods: We compared simultaneous nasal MRSA swabs (COPAN ESwabs ® 480C flocked nasal swab in 1mL of liquid Amies medium) and virals wabs (BD H192(07) flexible mini-tip flocked nasopharyngeal swabs in 3mL Universal Transport Medium) for SARS-CoV-2 PCR testing using Simplexa COVID-19 Direct assay on patients over a 4-day period. When the results were discordant, the viral swab sample was run again on the Cepheid Xpert Xpress ® SARS-CoV-2 assay.

Results: Of the 81 included samples, there were 19 positives and 62 negatives in viral media and 18 positives and 63 negative in the MRSA swabs. Amongst all included samples, there was concordance between the COPAN ESwabs ® 480C and the viral swabs in 78 (96.3%).

Conclusion: We found a high rate of concordance in test results between COPAN ESwabs ® 480C in Amies solution and BD H192(07) nasopharyngeal swabs in in 3 mL of Universal Viral Transport medium viral media. Clinicians and laboratories should feel better informed and assured using COPAN ESwabs ® 480C to help in the diagnosis of COVID-19.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Test esults on the Simplexa ® COVID-19 Direct Kit (DiaSorin) comparing viral swabs and MRSA swabs.
See this image and copyright information in PMC

References

    1. Zhu N, Zhang D, Wang W, et al. China novel coronavirus Investigating and Research Team. A novel coronarvirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382: 727–733. 10.1056/NEJMoa2001017 - DOI - PMC - PubMed
    1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV naming it SARS-CoV-2. Nat Microbiol. 2020; 5: 536–544. 10.1038/s41564-020-0695-z - DOI - PMC - PubMed
    1. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565–574. 10.1016/S0140-6736(20)30251-8 - DOI - PMC - PubMed
    1. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594... accessed April 24, 2020
    1. Haffajee RL, Mello MM. Thinking globally, acting locally-The U.S. response to Covid-19. N Engl J Med. 2020: 10.1056/NEJMp2006740 - DOI - PubMed

MeSH terms